Back to Search Start Over

Evaluation of smartphone oral contraceptive reminder applications.

Authors :
Gal N
Zite NB
Wallace LS
Source :
Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2015 Jul-Aug; Vol. 11 (4), pp. 584-7. Date of Electronic Publication: 2014 Dec 16.
Publication Year :
2015

Abstract

Background: Oral contraceptives (OCs) are the most widely used contraceptive method among women of reproductive age in the United States (US). Routine download and use of health-related smartphone applications (apps) continues to increase.<br />Objective: The purpose of this study was to evaluate the utility of English-language, smartphone-platform OC reminder apps currently available for download in the US.<br />Methods: During June-July 2013, official Internet-based, mobile app platforms for the two major smartphone operating systems in the US-Android (Google Play Store) and iPhone (iTunes)-were searched. "Birth control," "the pill," and "contraception" were entered into the search-bar of each Smartphone store. Apps were assessed for the following: cost, health care professionals' involvement in app development, reminder mechanisms, and functionality.<br />Results: Of the 39 unique OC reminder apps meeting inclusion criteria, 7 (18%) did not operate as intended when downloaded. Most apps functioned without an Internet connection (97%) and included pop-up notifications (84%).<br />Conclusions: Certain app features overcome common causes of missing an alarm, and hypothetically, may minimize likelihood of an OC user missing a daily pill. Health care providers should inform users of potential pitfalls and advise them that an OC reminder app should be not be used as a sole reminder method.<br /> (Copyright © 2015 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1934-8150
Volume :
11
Issue :
4
Database :
MEDLINE
Journal :
Research in social & administrative pharmacy : RSAP
Publication Type :
Academic Journal
Accession number :
25640888
Full Text :
https://doi.org/10.1016/j.sapharm.2014.11.001